December 30, 2019 6:39pm

Looking forward to 2019 ending

Cell and gene therapy investors need to be open to better intelligence for portfolio return(s) from RMi


 

The Dow closed down -178.67 points (-0.62%), the S&P closed down -16.70 points (-0.580.48%) and the NASDAQ closed down -60.62 points (-0.67%)

 

The iShares NASDAQ Biotechnology (IBB) and the SPDR S&P ETF (XBI) indicators:

  • Monday the IBB closed down -1.38% while and XBI closed down -1.49%
  • Friday the IBB closed down -1.02% while and XBI closed down -1.37%

 

The advance/decline line scenario of 45 covered companies:

  • Monday the close was negative with an A/D line of 9/28, 1 flat, 2 reversed merged (HSGX & ONVO), 2 dropped (BTX and CUR) and 3 acquired (ONCE, AST & OSIR);
  • Friday the close was negative with an A/D line of 10/26, 0 flat, 2 reversed merged (HSGX & ONVO), 2 dropped (BTX and CUR) and 3 acquired (ONCE, AST & OSIR);

 

Henry’omics:

The cell and gene therapy sector got ripped a new one as share pricing fell.

“Our” universe was overbought at the end of last week and … … nothing new has occurred to keep the sector up in the year-end.

While indexes fell from their all-time highs on Monday as investors took off some risk on the second-to-last trading day of a record-breaking year for equities.

 

Let's end it - 2019 and hope for a better year as January extends its reach into its final weeks!

 

Decliners:

  • CRISPR Therapeutics (CRSP -$4.17);
  • Alnylam Pharmaceuticals (ALNY -$2.85);
  • Sage therapeutics (SAGE -$1.76);
  • BioMarin Pharmaceuticals (BMRN -$1.00);
  • Editas Medicine (EDIT -0$0.96 after Friday’s -$1.590;

Incliners:

  • ReNeuron (RENE.L +$2.50 after Friday’s +$4.00, Thursday’s -$1.00, Tuesday’s -$1.00 and last Monday’s +$3.50);
  • ThermoGenesis (KOOL +$0.35 after Friday’s +$0.35 and Thursday’s +$0.35);
  • MiMedx (MDXG +$0.25);
  • Caladrius Biosciences (CLBS +$0.24 after Friday’s +$0.14);
  • BrainStorm Cell Therapeutics (BCLI +$0.20);

 

The percentage (%) indicators:

  • Monday’s range of the 9 upside was +0.09% (ADVM) to +10.31% (CLBS) while the 28 downside ranged from -0.03% (GBT) to -9.02% (BLCM); 
  • Friday’s range of the 10 upside was +0.06% (BOLD) to +7.31% (KOOL) while the 20 downside ranged from -0.20% (ALNY) to -8.27% (ADVM); 

 

Upside volume stats:  to compare

  • Monday: 2 out of the 9 upside had higher than the 3 month average volume;
  • Friday: 6 out of the 16 upside had higher than the 3 month average volume;

Downside volume stats:

  • Monday: 10 out of the 28 downside had higher than the 3 month average volume;
  • Friday: 7 out of the 20 downside had higher than the 3 month average volume;

 

1 flat – ADRO

 

December’s sessions:

Monday closed NEGATIVE with 28 decliners, 9 advancers, 1 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Friday closed NEGATIVE with 20 decliners, 10 advancers, 2 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Thursday closed NEGATIVE with 20 decliners, 16 advancers, 2 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Wednesday markets were closed;

Tuesday closed POSITIVE with 10 decliners, 27 advancers, 1 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Monday closed POSITIVE with 2 decliners, 35 advancers, 1 flat, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Friday closed NEGATIVE with 19 decliners, 15 advancers, 3 flats, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Thursday closed POSITIVE with 12 decliners, 24 advancers, 2 flats, 2 dropped (BTX & CUR) and 3 acquired (ONCE, AST & OSIR) and 2 reversed (HSGX & ONVO);

Wednesday closed NEGATIVE with 23 decliners, 13 advancers, 3 flat, 2 dropped (BTX & CUR) and 2 acquired (AST & OSIR) and 2 reversed (HSGX & ONVO);

Tuesday closed NEGATIVE with 22 decliners, 16 advancers, 1 flat, 2 dropped (BTX & CUR) and 2 acquired (AST & OSIR) and 2 reversed (HSGX & ONVO);

Monday closed POSITIVE with 13 decliners, 25 advancers, 1 flat, 2 dropped (BTX & CUR) and 2 acquired (AST & OSIR) and 2 reversed (HSGX & ONVO);

Friday closed NEGATIVE with 24 decliners, 16 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Thursday closed POSITIVE with 14 decliners, 27 advancers, 0 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Wednesday closed NEGATIVE with 13 decliners, 27 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Tuesday closed POSITIVE with 17 decliners, 22 advancers, 2 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Monday closed NEGATIVE with 31 decliners, 9 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Friday closed POSITIVE with 9 decliners, 29 advancers, 3 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Thursday closed NEGATIVE with 31 decliners, 9 advancers, 1 flat, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Wednesday closed POSITIVE with 13 decliners, 25 advancers, 4 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Tuesday closed POSITIVE with 12 decliners, 25 advancers, 4 flats, 1 dropped (BTX) and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

Monday closed NEGATIVE with 26 decliners, 19 advancers, 2 flats and 2 acquired (AST & OSIR) and 1 reversed (HSGX);

 

Opinions expressed are those of the author and are subject to change, and not intended to be a forecast of future events, a guarantee of future results, nor investment advice.

Whether information or intelligence is good, bad or somewhere in between; I put into context what is relevant and useful for investors.  All investments are subject to risks. Investors should consider investment objectives.

Henry McCusker, the editor and publisher of RegMed Investors does not hold or have positions in securities referred to in this publication.